Sessão de Encontro com o Autor – Tema Livre (Pôster)


Código

P55

Área Técnica

Glaucoma

Instituição onde foi realizado o trabalho

  • Principal: Universidade Federal de São Paulo (UNIFESP)

Autores

  • GUSTAVO ALBRECHT SAMICO (Interesse Comercial: NÃO)
  • Ricardo Abe (Interesse Comercial: NÃO)
  • Tiago Prata (Interesse Comercial: NÃO)
  • Sérgio Henrique Teixeira (Interesse Comercial: NÃO)
  • Augusto Paranhos (Interesse Comercial: NÃO)
  • Carolina Pelegrini Barbosa Gracitelli (Interesse Comercial: NÃO)

Título

RELATIONSHIP BETWEEN NUMBER OF GLAUCOMA MEDICATIONS, OCULAR SURFACE DISORDER AND TREATMENT ADHERENCE

Objetivo

Determine the relationship of ocular surface disease (OSD), the number of glaucoma medications prescribed and how it influences treatment adherence.

Método

In this cross-sectional study, glaucoma patients were submitted to demographic data collection, completing the OSD Index (OSDI) questionnaire and the glaucoma treatment compliance assessment tool (GTCAT). Ocular surface parameters were assessed by “Keratograph 5M”. Subjects were stratified into 2 groups according to the amount of prescribed ocular hypotensive eye drops (Group 1: one or two classes of medications; Group 2: three or four classes).

Resultado

Twenty-seven eyes of 27 glaucoma patients were included: 17 using 1 or 2 topical medications (group 1) and 10 eyes using 3 or 4 classes (group 2). For the Keratograph assessment, patients using 3 or more medications had significantly smaller tear meniscus height (TMH) (0.27 ± 0.10 vs. 0.43 ± 0.22; P = 0.037) FIGURE 1. Analysis of OSDI questionnaire showed higher scores among group using more hypotensive eye drops (18.67 ± 13.53 vs. 38.82 ± 19.72; P = 0.004) FIGURE 2. Regarding the GTCAT, group 2 had worse scores in components of forgetfulness (P = 0.027) and barriers due to lack of drops (P = 0.031).

Conclusão

The study found that glaucoma patients using more hypotensive eye drops had worse TMH and OSDI scores, compared to those using less topical medications. Patients using 3 or 4 classes of drugs had worse predictors of glaucoma adherence. Despite worse OSD results, there was no significant difference in self-reported side.

Promotor

Realização - CBO

Organização

Organizadora

Transporte Terrestre

Transporte Terrestre

Agência de Turismo

Agência Oficial de Turismo

Agência Web

Sistema de Gerenciamento desenvolvido por Inteligência Web

Patrocinador Platina

Genom
Johnson & Johnson

Patrocinador Ouro

Allergan

Patrocinador Prata

Alcon
Latinofarma

Patrocinador Bronze

Essilor
Ofta
Zeiss

Patrocínio

Roche

66º Congresso Brasileiro de Oftalmologia

07 a 10 de setembro de 2022 | Curitiba/PR

Política de privacidade